Keith Peden
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
Papers in
-
- RNA Interference and Gene Delivery 12
- Genetics 34
- Virus-based gene therapy research 27
- Co-authors
- James M. Pipas (17 shared papers)Daniel Nathans (8 shared papers)Michael Emerman (3 shared papers)Luc Montagnier (3 shared papers)Joshua Μ. Farber (6 shared papers)Robert H. Symons (3 shared papers)Rosemay Vazeux (1 shared paper)Sonia Pearson‐White (1 shared paper)
- Journals
- Journal of Virology (18 papers)Virology (11 papers)Molecular and Cellular Biology (8 papers)Biologicals (5 papers)Vaccine (5 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Keith Peden
108 papers receiving 5.5k citations
Keith Peden's Hit Papers
Peers
Comparison fields: 5 of 118
- Virology 1.9k
- Infectious Diseases 1.2k
- Immunology 1.3k
- Oncology 1.6k
- Genetics 1.3k
Countries citing papers authored by Keith Peden
This map shows the geographic impact of Keith Peden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Peden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Peden more than expected).
Fields of papers citing papers by Keith Peden
This network shows the impact of papers produced by Keith Peden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Peden. The network helps show where Keith Peden may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Peden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 359 | |
| 2 | Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI Hit paper breakdown → | 1991 | 345 |
| 3 | 1997 | 336 | |
| 4 | 1980 | 329 | |
| 5 | 1983 | 262 | |
| 6 | 1973 | 217 | |
| 7 | 1997 | 210 | |
| 8 | 1983 | 204 | |
| 9 | 1982 | 202 | |
| 10 | 1986 | 151 | |
| 11 | 1983 | 141 | |
| 12 | 1996 | 134 | |
| 13 | 1998 | 120 | |
| 14 | 2006 | 116 | |
| 15 | 1983 | 111 | |
| 16 | 1989 | 110 | |
| 17 | 1989 | 106 | |
| 18 | 1983 | 94 | |
| 19 | 1989 | 87 | |
| 20 | 1986 | 87 |
About Keith Peden
Keith Peden is a scholar working on Molecular Biology, Genetics, Oncology, Virology and Infectious Diseases, having authored 110 papers that have together received 5.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (28 papers), Virus-based gene therapy research (27 papers), Polyomavirus and related diseases (23 papers), Bacteriophages and microbial interactions (21 papers), HIV/AIDS drug development and treatment (14 papers), Immune Cell Function and Interaction (13 papers), RNA Interference and Gene Delivery (12 papers) and Herpesvirus Infections and Treatments (9 papers). The work is most often cited by research in Virology (1.9k citations), Infectious Diseases (1.2k citations), Immunology (1.3k citations), Oncology (1.6k citations) and Genetics (1.3k citations). Keith Peden has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James M. Pipas, Daniel Nathans, Michael Emerman, Luc Montagnier, Joshua Μ. Farber, Robert H. Symons, Rosemay Vazeux, Sonia Pearson‐White, Phoebe Mounts and Andrew M. Lewis. Their work appears in journals such as Journal of Virology, Virology, Molecular and Cellular Biology, Biologicals and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.